Search results for "Metabolic disease"

showing 10 items of 778 documents

Sarcopenia and appendicular muscle mass as predictors of impaired fasting glucose/type 2 diabetes in elderly women

2021

Elderly women exhibit a high risk of type 2 diabetes (T2D), but no definitive data exist about the possible role of postmenopausal increases in visceral adiposity, the loss of lean body mass, or decreases in the sum of the lean mass of arms and legs (appendicular skeletal muscle mass (ASMM)). This retrospective, longitudinal study investigated whether body composition (bioelectrical impedance analysis) predicted the development of impaired fasting glucose (IFG) or T2D in a cohort of 159 elderly women (age: 71 ± 5 years, follow-up: 94 months) from southern Italy (Clinical Nutrition and Geriatric Units of the “Mater Domini” University Hospital in Catanzaro, Calabria region, and the “P. Giacco…

endocrine system diseasesappendicular skeletal muscle mass.Type 2 diabetes030204 cardiovascular system & hematologyBody Mass IndexCohort StudiesEating0302 clinical medicineTX341-641Longitudinal StudiesSettore MED/49 - Scienze Tecniche Dietetiche ApplicateSicilyNutrition and DieteticsHand StrengthdiabetesFastingaging; appendicular skeletal muscle mass; body composition; diabetes; nutrition; sarcopenianutritionItalydiabetes; aging; nutrition; body composition; sarcopenia; appendicular skeletal muscle mass.FemaleBioelectrical impedance analysisappendicular skeletal muscle massmedicine.medical_specialtyWaist030209 endocrinology & metabolismClinical nutritionArticlesarcopenia03 medical and health sciencesMuscular DiseasesDiabetes mellitusInternal medicinemedicineHumansMuscle StrengthMuscle SkeletalAgedRetrospective Studiesbody compositionNutrition. Foods and food supplybusiness.industryagingnutritional and metabolic diseasesImpaired fasting glucosemedicine.diseaseGlucoseDiabetes Mellitus Type 2diabeteSarcopeniaLean body massbusinessFood Science
researchProduct

RAGE Mediates a Novel Proinflammatory Axis

1999

S100/calgranulin polypeptides are present at sites of inflammation, likely released by inflammatory cells targeted to such loci by a range of environmental cues. We report here that receptor for AGE (RAGE) is a central cell surface receptor for EN-RAGE (extracellular newly identified RAGE-binding protein) and related members of the S100/calgranulin superfamily. Interaction of EN-RAGEs with cellular RAGE on endothelium, mononuclear phagocytes, and lymphocytes triggers cellular activation, with generation of key proinflammatory mediators. Blockade of EN-RAGE/RAGE quenches delayed-type hypersensitivity and inflammatory colitis in murine models by arresting activation of central signaling pathw…

endocrine system diseasesbiologyBiochemistry Genetics and Molecular Biology(all)nutritional and metabolic diseasesInflammationS100A12 ProteinGeneral Biochemistry Genetics and Molecular BiologyCell biologyRAGE (receptor)Proinflammatory cytokineCell surface receptorImmunologycardiovascular systembiology.proteinmedicineCalgranulincardiovascular diseasesmedicine.symptomSignal transductionReceptorhuman activitiesCell
researchProduct

Extracellular Vesicle Encapsulated MicroRNAs in Patients with Type 2 Diabetes Are Affected by Metformin Treatment

2019

Recently, microRNAs (miRNAs) in circulating extracellular vesicles (EVs), have emerged as a source of potential biomarkers for various pathophysiological conditions, including metabolic disorders such as diabetes. Type 2 diabetes mellitus (T2DM), is the most prevalent form of diabetes in the USA, with 30 million diagnosed patients. Identifying miRNA biomarkers that can be used to assess response to glucose lowering treatments would be useful. Using patient plasma samples from a subset of the Danish Metagenomics of the Human Intestinal Tract (MetaHIT) cohort, we characterized miRNAs from whole plasma, plasma-derived EVs, and EV-depleted plasma by small RNA-sequencing to identify T2DM associa…

endocrine system diseaseslcsh:Medicine030209 endocrinology & metabolismType 2 diabetesPharmacologyArticle03 medical and health sciences0302 clinical medicineDiabetes mellitusmicroRNAmedicine030304 developmental biology0303 health sciencesbusiness.industrylcsh:RType 2 Diabetes Mellitusnutritional and metabolic diseasesGeneral MedicineExtracellular vesiclemedicine.diseasePathophysiology3. Good healthMetforminmicroRNAsCohorttype 2 diabetesbusinessextracellular vesiclesmetforminmedicine.drugJournal of Clinical Medicine
researchProduct

Origin of Insulin Receptor-Like Tyrosine Kinases in Marine Sponges

1999

One autapomorphic character restricted to all Metazoa including Porifera [sponges] is the existence of transmembrane receptor tyrosine kinases (RTKs). In this study we screened for molecules from one subfamily within the superfamily of the insulin receptors. The subfamily includes the insulin receptors (InsR), the insulin-like growth factor I receptors, and the InsR-related receptors--all found in vertebrates--as well as the InsR-homolog from Drosophila melanogaster. cDNAs encoding putative InsRs were isolated from the hexactinellid sponge Aphrocallistes vastus, the demosponge Suberites domuncula, and the calcareous sponge Sycon raphanus. Phylogenetic analyses of the catalytic domains of th…

endocrine systemDNA ComplementarySubfamilyMolecular Sequence DataReceptor tyrosine kinaseEvolution MolecularMiceDemospongeCatalytic DomainBotanyAnimalsHumansAmino Acid SequenceSycon raphanusCloning MolecularPhylogenyCephalochordateBase SequenceSequence Homology Amino Acidbiologygeodia cydonium; adhesion receptors; evolutionnutritional and metabolic diseasesSequence Analysis DNAbiology.organism_classificationReceptor InsulinPoriferaRatsSuberites domunculaInsulin receptorSpongeBiochemistrybiology.proteinGeneral Agricultural and Biological Scienceshormones hormone substitutes and hormone antagonistsThe Biological Bulletin
researchProduct

Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective …

2018

Introduction DPP-4 inhibitors (DPP4i) and sulfonylureas are popular second-line therapies for type 2 diabetes (T2D), but there is a paucity of real-world studies comparing their effectiveness in routine clinical practice. Methods This was a multicenter retrospective study on diabetes outpatient clinics comparing the effectiveness of DPP4i versus gliclazide extended release. The primary endpoint was change from baseline in HbA1c. Secondary endpoints were changes in fasting plasma glucose, body weight, and systolic blood pressure. Automated software extracted data from the same clinical electronic chart system at all centers. Propensity score matching (PSM) was used to generate comparable coh…

endocrine systemmedicine.medical_specialtyEpidemiologyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematologyDatabase03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes mellitusInternal medicinemedicineClinical endpointDatabase; Epidemiology; Pharmacotherapy; Internal Medicine; Endocrinology Diabetes and MetabolismInternal MedicineOutpatient clinicGliclazideOriginal ResearchGlycemicbusiness.industrynutritional and metabolic diseasesDatabase; Epidemiology; PharmacotherapyRetrospective cohort studymedicine.diseasePharmacotherapyMetforminDiabetes and Metabolismbusinessmedicine.drug
researchProduct

Personality types in individuals with type 1 and type 2 diabetes

2020

Objective The Type A personality, characterized by impatience, strong career ambition and competitiveness, is associated with greater sensitivity to external stress. Type 1 diabetes (T1D) is an auto-immune disease, which is potentially influenced by stress, unlike type 2 diabetes (T2D). The aim of this study was to assess whether individuals with T1D and T2D exhibited significant differences on the Type A personality scale. We also assessed personality in patients with thyroid auto-immune diseases to validate potential links between auto-immune disease and Type A personality. Design and methods The Bortner questionnaire was used to assess Type A personality in 188 patients with T1D, 430 pa…

endocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedia_common.quotation_subject030209 endocrinology & metabolismDiseaseType 2 diabeteslcsh:Diseases of the endocrine glands. Clinical endocrinology03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineDiabetes mellitusInternal MedicinemedicinePersonalitythyroid disease030212 general & internal medicinetype a personalityauto-immunitymedia_commonType 1 diabeteslcsh:RC648-665business.industryResearchThyroid diseaseThyroidnutritional and metabolic diseasesType A and Type B personality theorymedicine.diseasemedicine.anatomical_structurediabetes mellitusbusinessEndocrine Connections
researchProduct

Mipomersen: a lipid-lowering agent with a novel mechanism of action

2013

“...mipomersen is a ... valuable alternative to apheresis for patients with heterozygous familial hypercholesterolemia.”

inorganic chemicalsLdl cholesterolChemistryEndocrinology Diabetes and MetabolismMipomersenLipid-lowering agentnutritional and metabolic diseasesPharmacologybehavioral disciplines and activitieshumanitiesantisense oligonucleotides LDL cholesterol lipid lowering mipomersen statinsApheresisMechanism of actionAntisense oligonucleotidesmedicineLipid loweringmedicine.symptomCardiology and Cardiovascular Medicinehealth care economics and organizationsClinical Lipidology
researchProduct

The iron-regulatory hormone hepcidin: A possible therapeutic target?

2015

The maintenance of stable extracellular and intracellular iron concentrations requires the coordinated regulation of iron transport into plasma. Iron is a fundamental cofactor for several enzymes involved in oxidation-reduction reactions. The redox ability of iron can lead to the production of oxygen free radicals, which can damage various cellular components. Therefore, the appropriate regulation of systemic iron homeostasis is decisive in vital processes. Hepcidin has emerged as the central regulatory molecule of systemic iron homeostasis. It is synthesized in hepatocytes and in other cells and released into the circulation. It inhibits the release of iron from enterocytes of the duodenum…

inorganic chemicalscongenital hereditary and neonatal diseases and abnormalitiesIronFerroportinRegulatorInflammationdigestive system03 medical and health sciences0302 clinical medicineHepcidins[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemHepcidinhemic and lymphatic diseasesmedicineExtracellularAnimalsHumansPharmacology (medical)Cation Transport ProteinsComputingMilieux_MISCELLANEOUS030304 developmental biologyPharmacology0303 health sciencesbiologyChemistrynutritional and metabolic diseasesMetabolism[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system3. Good healthLiverBiochemistryCardiovascular DiseasesCytoprotection030220 oncology & carcinogenesisbiology.proteinmedicine.symptomIntracellularHomeostasis
researchProduct

Retracted: Targeting Mitochondria as Therapeutic Strategy for Metabolic Disorders.

2019

Mitochondria are critical regulator of cell metabolism; thus, mitochondrial dysfunction is associated with many metabolic disorders. Defects in oxidative phosphorylation, ROS production, or mtDNA mutations are the main causes of mitochondrial dysfunction in many pathological conditions such as IR/diabetes, metabolic syndrome, cardiovascular diseases, and cancer. Thus, targeting mitochondria has been proposed as therapeutic approach for these conditions, leading to the development of small molecules to be tested in the clinical scenario. Here we discuss therapeutic interventions to treat mitochondrial dysfunction associated with two major metabolic disorders, metabolic syndrome, and cancer. …

lcsh:Tlcsh:Rlcsh:MedicineReview ArticleDNA Mitochondriallcsh:TechnologyOxidative PhosphorylationRetractionMitochondriaMetabolic DiseasesMutationHumanslcsh:QReactive Oxygen Specieslcsh:ScienceTheScientificWorldJournal
researchProduct

Anti-inflammatory effects of GLA and EPA on a scopolamine-induced dry eye rat model

2007

International audience; Purpose:: The aim of this study was to evaluate the potential anti-inflammatory effects of dietary γ-linolenic acid (GLA) and eicosapentaenoic acid (EPA) in a scopolamine-induced dry eye rat model. Methods:: Female Lewis rats were fed with 5%-lipid diets containing 10% of either GLA or EPA. After two months of feeding, we induced dry eye syndrome using scopolamine continuously delivered via osmotic pumps for 2, 10 and 28 days. At the end of the treatment period, we performed fluorescein staining on the cornea. We sacrificed the animals and excised the ocular tissues and the exorbital lacrimal glands. We immunostained MHCII and mucin MUC5AC on ocular sphere cryosectio…

lipids[SDV] Life Sciences [q-bio]keratitisinflammation[SPI.GPROC] Engineering Sciences [physics]/Chemical and Process Engineering[SDV]Life Sciences [q-bio][SDV.IDA]Life Sciences [q-bio]/Food engineeringnutritional and metabolic diseaseslipids (amino acids peptides and proteins)[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process Engineering[SDV.IDA] Life Sciences [q-bio]/Food engineering
researchProduct